Clinical trial
Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of…
NCT00235079 · Azienda Sanitaria Locale 3, Torino, Other · Completed
Key facts
| NCT number | NCT00235079 |
|---|---|
| Title | Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment. |
| Official title | Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The CORP 2 Trial: COlchicine for Recurrent Pericarditis. |
| Acronym | CORP 2 |
| Lead sponsor | Azienda Sanitaria Locale 3, Torino, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pericarditis, Recurrence |
| Intervention type | Drug |
| Interventions | Colchicine, Placebo |
| Enrollment | 240 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Oct 10, 2005 |
| Last update posted | Aug 7, 2013 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: